CellFold Overview
- Year Founded
-
2025
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
CellFold General Information
Description
Developer of regenerative cell therapy and vascular regeneration technology designed for the treatment of severe limb ischemia and other ischemic diseases. The company's technology combines an injectable cell scaffold with autologous mononuclear cells rich in CD34-positive stem cells to promote angiogenesis and supports exploratory and confirmatory clinical trials for chronic limb-threatening ischemia, enabling healthcare providers to deliver accessible, cost-efficient and efficacious regenerative care.
Contact Information
Website
www.cellfold.jpCorporate Office
- Floor 6, N&E Building
- 1-12-4 Ginza Chuo-ku
- Tokyo, 104-0061
- Japan
Corporate Office
- Floor 6, N&E Building
- 1-12-4 Ginza Chuo-ku
- Tokyo, 104-0061
- Japan
CellFold Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 30-Sep-2025 | Completed | Generating Revenue |
CellFold Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| FASTAR | Accelerator/Incubator |
CellFold FAQs
-
When was CellFold founded?
CellFold was founded in 2025.
-
Where is CellFold headquartered?
CellFold is headquartered in Tokyo, Japan.
-
What industry is CellFold in?
CellFold’s primary industry is Biotechnology.
-
Is CellFold a private or public company?
CellFold is a Private company.
-
What is CellFold’s current revenue?
The current revenue for CellFold is .
-
Who are CellFold’s investors?
FASTAR has invested in CellFold.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process